Program for Emotional and Physical Pain - Pilot Randomized Clinical Trial

NCT ID: NCT01769729

Last Updated: 2014-12-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-12-31

Study Completion Date

2014-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The overall aim of this program of research is to develop a collaborative psychotherapy for major depressive disorder (MDD) specifically for primary care patients with MDD and comorbid chronic low back pain (CLBP).

The purpose of the proposed project is to establish the feasibility and acceptability of a research design for an eventual large-scale randomized clinical trial which would test the efficacy of PEPP in comparison to a control condition (depression care management).

To achieve the investigators specific aims, the investigators will conduct a pilot randomized clinical trial (n = 30), with two treatment arms; PEPP (which includes procedures used in care management) or care management.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The overall aim of this program of research is to develop a collaborative psychotherapy for major depressive disorder (MDD) specifically for primary care patients with MDD and comorbid chronic low back pain (CLBP). The newly developed intervention will integrate and build on behavior therapy for MDD and behavior therapy for chronic pain towards a key target of reducing behavioral avoidance. This 4-month collaborative psychotherapy, entitled Program for Emotional and Physical Pain (PEPP), will include 1 joint meeting with the behavioral health specialist (BHS), primary care provider (PCP), and patient, 10 psychotherapy sessions, and continued collaboration between the BHS and the PCP to assure a shared treatment plan.

The purpose of the proposed project is to establish the feasibility and acceptability of a research design for an eventual large-scale randomized clinical trial which would test the efficacy of PEPP in comparison to a control condition (depression care management)..

To achieve the investigators specific aims, the investigators will conduct a pilot randomized clinical trial (n = 30), with two treatment arms; PEPP (which includes procedures used in care management) or care management. The specific aims are:

1. To develop and refine PEPP so that it meets standards of feasibility and acceptability for primary care physicians (PCPs), behavioral health specialists (BHSs), and participants;

1. To develop, field-test, and finalize a PEPP manual;
2. To develop a reliable measure of BHS adherence to the manual;
3. To develop, field-test, and finalize BHS training and supervision procedures;
2. To field-test and finalize procedures for depression care management;
3. To establish that the investigators can adequately provide depression care management and that it is acceptable in this population;
4. To develop and refine recruitment methods for an RCT and document an adequate rate of recruitment;
5. To refine research procedures, e.g., consent process, randomization process, and assessment procedures, and establish their feasibility and acceptability to participants.

Ultimately, the investigators expect that this treatment development work will prepare us to apply for an R01 to conduct a large-scale, adequately powered RCT with the same research design as the pilot RCT proposed in this application. Depression will be the primary outcome variable assessed in the large-scale RCT; pain will be a secondary outcome variable. In the end, the investigators believe this line of work will lead to the incorporation into primary care of theoretically-driven and effective mental health treatment for patients with MDD and comorbid CLBP. To the best of the investigators knowledge, this would be the first empirically-tested psychotherapy protocol that specifically integrates treatment of major depression with CLBP.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Depression Chronic Low Back Pain

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

integrated primary care depression chronic low back pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

PEPP + care management

This 4-month collaborative psychotherapy, entitled Program for Emotional and Physical Pain (PEPP), will include 1 joint meetings with the behavioral health specialist (BHS), primary care provider (PCP), and patient, 10 psychotherapy sessions, and continued collaboration between the BHS and the PCP to assure a shared treatment plan.

Care management will include monthly calls with a depression care manager.

Group Type EXPERIMENTAL

PEPP

Intervention Type BEHAVIORAL

Care management

Intervention Type BEHAVIORAL

Care management alone

Care management will include monthly calls with a depression care manager.

Group Type ACTIVE_COMPARATOR

Care management

Intervention Type BEHAVIORAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

PEPP

Intervention Type BEHAVIORAL

Care management

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Meets DSM-IV criteria for current major depressive disorder.
2. Participants must have a Quick Inventory of Depressive Symptoms (QIDS) score \>11.
3. Chronic low back pain. Pain must be \> 6 months duration, in the low back (lumbar region), present \> ½ the days of the month, and, on average, be of at least a moderate level of severity in the last month (\> 4 on an 11-point numerical rating of pain intensity ranging from 0 \[no pain\] to10 \[worst pain imaginable\]. Pain-related disability / functional impact of pain must be of at least moderate severity at the time of intake, determined by a score of at \> 7 on the Roland Morris Disability Questionnaire (RMDQ; (Roland \& Morris, 1983))
4. Continued pain despite having attempted initial steps of PCP guideline-based care (Chou et al., 2007). Participants must have been under the care of a physician for low back pain for \> 6 months and have already had \> 2 trials of recommended medications (i.e., acetaminophen, NSAIDs, skeletal muscle relaxants, opioids, and/or benzodiazepines).This will be judged through chart review and interviews with patients \& PCPs.
5. Antidepressant dose stable for previous 2 months. If the participant is taking an antidepressant, he/ she must have been on the same dose for the previous 2 months.
6. Aged 18 or older.
7. Have a PCP at one of our enrollment sites.

Exclusion Criteria

1. Lifetime diagnosis of bipolar disorder, schizophrenia, or other chronic psychotic condition.
2. Current hazardous illicit drug or alcohol use assessed with the AUDIT and DUDIT.
3. Opiate misuse will be assessed with the COMM and via primary care chart review.
4. Suicidal ideation or behavior requiring immediate attention.
5. In psychotherapy or in a multidisciplinary pain management program at baseline.
6. Anticipate having surgery in the next 6 months.
7. Pain thought to be due to visceral disease, cancer, infection, or inflammatory arthritis or pain associated with severe or progressive neurological deficits.
8. Current pregnancy
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institute of Mental Health (NIMH)

NIH

Sponsor Role collaborator

Butler Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lisa Uebelacker, PhD

Role: PRINCIPAL_INVESTIGATOR

Butler Hospital, Brown University

Risa Weisberg, PhD

Role: PRINCIPAL_INVESTIGATOR

Brown University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Family Care Center of Memorial Hospital

Pawtucket, Rhode Island, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R34MH085762

Identifier Type: NIH

Identifier Source: secondary_id

View Link

MH085762

Identifier Type: -

Identifier Source: org_study_id